Upvote
Downvote
Director, Global HEOR & RWE
Share Job
- Suggest Revision
- The Global Director of HEOR & RWE Oncology will lead the HEOR and RWE implementation and evidence generation for a successful market access strategy across Daiichi-Sankyo.
- He/She will drive the asset specific HEOR strategy and coordinate all corresponding HEOR and RWE activities under the Global Oncology Market Access & Pricing department for the Oncology Business Unit, in collaboration with cross-functional teams.
- The role will be responsible for the HEOR and RWE strategy and tactical plans, including the implementation of global health economic models, global value dossiers, RWE studies, PRO analysis, and will drive development of innovative tools, methods, and strategies to ensure successful market access and support the company's vision of being a leader in oncology and deliver the innovative Daiichi Sankyo's treatments to patient.
- The Director will provide HEOR and RWE strategic direction to Global Project Teams (GPTs) and Global Brand Teams (GBTs) and provide recommendations on such aspects as appropriate comparators, target patient populations, clinical and economic end-points and patient-reported outcomes (PROs), ensuring the payer perspective is incorporated in the assigned clinical development programs and the evidence needed to support optimal market access.
- Lead the preparation of global value dossiers which present the product value propositions and the supporting evidence, aligned with the product development strategies and approved/endorsed by the GPTs, GBTs, Regional HEOR and market access, to realize an optimal value demonstration of the products
Active Job
Updated TodaySimilar Job
Relevance
Active